Florida Legal News & Updates | Orlando Legal Examiner

Trasylol Risks Outweigh Rewards

Trasylol, the anti-bleeding agent used with patients undergoing cardiac surgery, has been found to increase the risk of death by 50%. A five-year study of 3876 patients given aprotinin also had a significantly higher death rate than those given two similar drugs to prevent bleeding. Researchers from

By The Legal Examiner

/ 8 Feb 2007

Journal of the American College of Cardiology: Drugs Can Be As Effective as Stents

The Wall St. Journalcites a study published in the American College of Cardiology that certain drugs are proven to be more effective than cardiac stents in improving blood flow through the coronary arteries in patients who were stable after a heart attack. The study also contends that for those with

By The Legal Examiner

/ 23 Jan 2007

Potential Link Between Heart Drugs and Parkinson's Leads to Investigation

Recent research linking statin heart drugs with Parkinson’s disease has led to an investigation involving tens of thousands of new patients. Researchers in the US are sufficiently troubled by the potential link that they will launch a full trial involving upwards of 16,000 participants. If the link

By The Legal Examiner

/ 16 Jan 2007

Two Parkinson's Drugs Linked to Heart Valve Problems

According to an article published in the Wall St. Journal, the drugs pergolide and cabergoline have been found to cause heart valve damage at an alarmingly high rate (4-7 times). The study was published in the New England Journal of Medicine and has renewed calls for the drugs to be discontinued. Va

By The Legal Examiner

/ 4 Jan 2007

Link Between Some Heartburn Drugs and Hip Injuries

A study published this week in The Jouranl of the American Medical Association, there is a connection between hip fractures and certain heartburn drugs such as Prilosec, Nexium, and Prevacid. All three medications are proton pump inhibitors. The largest risk was found in those taking large doses of

By The Legal Examiner

/ 28 Dec 2006

Kava Kava lawsuit to be filed

I will be filing a lawsuit in Orlando this Tuesday December 19, 2006 against Nutraceutical Corporation and Chamberlin Foods of Orlando for their manufacturing and distribution of the dangerous kava kava supplement. Kava Kava, a plant indigenous to the South Pacific is used as a ceremonial drink in t

By The Legal Examiner

/ 17 Dec 2006

Kava Kava- A Dangerous Drug

Kava Kava, known for its mood enhancing capacity, is coming under increasing scrutiny after studies have shown it to cause liver toxicity, even death. There are many forms of Kava Kava and it can be ingested in pill form or liquid tea. Its popularity has given rise to various Kava Kava bars popping

By The Legal Examiner

/ 6 Dec 2006

Polk County Corrections Officer Charged with Molesting Child

A Polk County Corrections officer has been charged with sexually molesting a victim under the age of 12. Officer Randy Gene Allen was arrested and charged with the crime on Monday. Allen is in jail with his bail set at $50,000 for each count

By The Legal Examiner

/ 5 Dec 2006

Problems with Heart Stents

According to a Cleveland Clinic analysis, drug coated stents increase the risk of dangerous blood clots four to five times more than the bare metal stents. The analysis covered 6,675 patients in 9 trials involving Johnson & Johnson and Boston Scientific.

By The Legal Examiner

/ 1 Dec 2006

Bausch & Lomb's Failure to Report

According to a federal warning letter, Bausch & Lomb, the maker of ReNu contact lens solution, failed to report more than 35 foreign cases of fungal eye infection. According to an Associated Press report, “Bausch & Lomb didn’t report the 35 serious injury reports by April 7, as required by law, afte

By The Legal Examiner

/ 7 Nov 2006

Safety of Drug Coated Heart Stents Still Up in the Air

After the third day of Transcather Cardiovascular Therapeutics show, the results are still mixed regarding the safety of drug coated heart stents. The stents, manufactured by Boston Scientific’s Taxus and Johnson & Johnson’s Cypher, many experts agreed, there appears to be a long-term clotting risk

By The Legal Examiner

/ 25 Oct 2006

Bayer's Tardy Report to FDA

Bayer AG has failed to disclose to regulators potentially serious safety concerns about its antibleeding drug Trasylol. The FDA has disclosed that preliminary test results indicate that the drug may cause serious kidney damage, congestive heart failure and strokes and an increased risk of death.

By The Legal Examiner

/ 3 Oct 2006